Company Filing History:
Years Active: 2003-2007
Title: The Innovative Mind of Linda C. Murray
Introduction: Linda C. Murray is a notable inventor located in Noblesville, IN, with a solid portfolio that includes two significant patents. Her contributions to the pharmaceutical industry are exemplified through her innovative formulations aimed at improving drug efficacy and delivery methods.
Latest Patents: Linda's latest inventions focus on the formulation of 2-methyl-thieno-benzodiazepine. Her patents provide a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate, along with novel olanzapine pamoate salts or solvates thereof. These advancements represent a considerable step forward in the development of effective therapeutic options.
Career Highlights: Linda works at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in healthcare. Her expertise and research efforts contribute to the company's mission of delivering high-quality pharmaceuticals that improve patients' lives.
Collaborations: In her role, Linda has collaborated with notable colleagues such as Douglas J. Allen and Kurt D. Dekemper. These collaborations enhance the research environment, fostering a culture of innovation that drives significant breakthroughs in the field of pharmaceutical sciences.
Conclusion: Linda C. Murray's innovative work exemplifies the impact that dedicated inventors can have on the pharmaceutical industry. With her patents addressing crucial formulation challenges, she plays a vital role in advancing drug delivery systems and improving patient outcomes.